Share

May 07, 2013; 80 (19) Article

Cognitive reserve and cortical atrophy in multiple sclerosis

A longitudinal study

Maria Pia Amato, Lorenzo Razzolini, Benedetta Goretti, Maria Laura Stromillo, Francesca Rossi, Antonio Giorgio, Bahia Hakiki, Marta Giannini, Luisa Pastò, Emilio Portaccio, Nicola De Stefano
First published April 10, 2013, DOI: https://doi.org/10.1212/WNL.0b013e3182918c6f
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
472

Share

Article Information

vol. 80 no. 19 1728-1733
DOI: 
https://doi.org/10.1212/WNL.0b013e3182918c6f
PubMed: 
23576622
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received August 8, 2012
  • Accepted in final form January 2, 2013
  • First Published April 10, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Maria Pia Amato, MD,
    2. Lorenzo Razzolini, MD,
    3. Benedetta Goretti, PhD,
    4. Maria Laura Stromillo, MD,
    5. Francesca Rossi, MD,
    6. Antonio Giorgio, MD,
    7. Bahia Hakiki, MD,
    8. Marta Giannini, MD,
    9. Luisa Pastò, MD,
    10. Emilio Portaccio, MD and
    11. Nicola De Stefano, MD
  1. Maria Pia Amato, MD,
    2. Scientific Advisory Boards:

    1. member of the Advisory Board, Biogen-Idec, Merck Serono, Bayer Schering, Teva, Novartis and Sanofi Aventis

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. honoraria for speaking from Biogen-Idec, Merck Serono, Bayer Schering, Novartis , Teva and Sanofi Aventis

    Editorial Boards:

    1. Member of Editorial Board and Associate Editor of BMC Neurology

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. research grants from Biogen Idec, Merk Serono, Bayer Shering, Sanophi Aventis, Teva

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Lorenzo Razzolini, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Funding for travel to Scientific Congresses by Novartis

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. one research grant by Novartis

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Benedetta Goretti, PhD,
    4. Scientific Advisory Boards:

    1. Dr. Goretti serves on a scientific advisory board for Biogen

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Dr. Goretti receives honoraria for speaking from Biogen, Teva and Novartis

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Dr. Goretti receives research support from Biogen, Merck, Novartis

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Maria Laura Stromillo, MD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Francesca Rossi, MD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Antonio Giorgio, MD,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Bahia Hakiki, MD,
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Marta Giannini, MD,
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. Luisa Pastò, MD,
    10. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  10. Emilio Portaccio, MD and
    11. Scientific Advisory Boards:

    1. Dr. Portaccio serves on a scientific advisory board for Biogen-Idec, Merck Serono and Bayer

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Honoraria and research grants from Merck Serono, Biogen Dompè, Bayer Schering, Sanofi Aventis, Teva

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  11. Nicola De Stefano, MD
    12. Scientific Advisory Boards:

    1. Prof. N. De Stefano serves on scientific advisory boards for Merck- Serono.

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Travel expense refunds from Teva and Merck-Serono.

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Honoraria for lectures from Teva, BioMS, Biogen-Idec, Bayer Schering Pharma and Merck-Serono.

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology (M.P.A., L.R., B.G., B.H., M.G., L.P., E.P.), University of Florence; Don Gnocchi Foundation (L.R., B.H., E.P.), Florence; and Department of Neurological and Behavioural Sciences (M.L.S., F.R., A.G., N.D.S.), University of Siena, Italy.
  1. Correspondence to Prof. Amato: mariapia.amato{at}unifi.it

Article usage

Article usage: April 2013 to October 2023

AbstractFullPdfSource
Apr 2013477249Highwire
May 2013234165118Highwire
Jun 20132591922Highwire
Jul 2013196920Highwire
Aug 2013105511Highwire
Sep 2013121611Highwire
Oct 201396910Highwire
Nov 201382715Highwire
Dec 201314015Highwire
Jan 201484810Highwire
Feb 20146433Highwire
Mar 2014611110Highwire
Apr 20146147Highwire
May 20144424Highwire
Jun 20144725Highwire
Jul 20146477Highwire
Aug 20143701Highwire
Sep 20143321Highwire
Oct 20143302Highwire
Nov 20145135Highwire
Dec 20143912Highwire
Jan 20153033Highwire
Feb 20155158Highwire
Mar 20154624Highwire
Apr 20152423Highwire
May 20153524Highwire
Jun 20153611Highwire
Jul 20153902Highwire
Aug 20153821Highwire
Sep 20153412Highwire
Oct 20152122Highwire
Nov 20152234Highwire
Dec 20152611Highwire
Jan 20161933Highwire
Feb 20163612Highwire
Mar 20162243Highwire
Apr 20162743Highwire
May 20163501Highwire
Jun 20162621Highwire
Jul 20163212Highwire
Aug 20163810Highwire
Sep 20163531Highwire
Oct 20165713Highwire
Nov 20161501Highwire
Dec 20162003Highwire
Jan 20171846Highwire
Feb 20171103Highwire
Mar 20173025Highwire
Apr 20171734Highwire
May 20172163Highwire
Jun 20171000Highwire
Jul 2017812Highwire
Aug 2017521Highwire
Sep 20171000Highwire
Oct 20171710Highwire
Nov 20171112Highwire
Dec 20172200Highwire
Jan 20182500Highwire
Feb 20183831Highwire
Mar 20183235Highwire
Apr 20181600Highwire
May 20183111Highwire
Jun 20181200Highwire
Jul 20183322Highwire
Aug 20182800Highwire
Sep 20186831Highwire
Oct 20184310Highwire
Nov 20183811Highwire
Dec 20181311Highwire
Jan 20192341Highwire
Feb 20192423Highwire
Mar 20193822Highwire
Apr 20192440Highwire
May 20193401Highwire
Jun 20192511Highwire
Jul 20192431Highwire
Aug 20191724Highwire
Sep 20191000Highwire
Oct 20195800Highwire
Nov 20194110Highwire
Dec 20192413Highwire
Jan 20202921Highwire
Feb 20202422Highwire
Mar 20202000Highwire
Apr 20203322Highwire
May 20208811Highwire
Jun 20203422Highwire
Jul 20202100Highwire
Aug 20203804Highwire
Sep 20203710Highwire
Oct 20204802Highwire
Nov 20203011Highwire
Dec 20203011Highwire
Jan 20213641Highwire
Feb 20214221Highwire
Mar 20212800Highwire
Apr 20213200Highwire
May 20212633Highwire
Jun 20214820Highwire
Jul 20214610Highwire
Aug 20215600Highwire
Sep 20217921Highwire
Oct 20212900Highwire
Nov 20213622Highwire
Dec 20212501Highwire
Jan 20223021Highwire
Feb 20224222Highwire
Mar 20223410Highwire
Apr 20223741Highwire
May 20223701Highwire
Jun 20226000Highwire
Jul 20224101Highwire
Aug 20223500Highwire
Sep 20223931Highwire
Oct 20224411Highwire
Nov 20224722Highwire
Dec 20223700Highwire
Jan 20235020Highwire
Feb 20233600Highwire
Mar 20234522Highwire
Apr 20233921Highwire
May 20233521Highwire
Jun 20233400Highwire
Jul 20233100Highwire
Aug 20232300Highwire
Sep 20235122Highwire
Oct 20235801Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles